New pill aims to curb relentless hunger in rare genetic disorder
Symptom relief
Not yet recruiting
This study tests an experimental drug called BMB-101 in 16 adults with Prader-Willi syndrome, a condition that causes constant, severe hunger. The goal is to see if the drug can safely reduce that hunger and improve daily life. Participants will be randomly assigned to receive ei…
Phase: PHASE2 • Sponsor: Bright Minds Biosciences Pty Ltd • Aim: Symptom relief
Last updated May 11, 2026 20:47 UTC